Repligen Corp (RGEN) has a current Price-to-Book (P/B) ratio of 4.44. Compared to its 3-year average P/B ratio of 4.27, the current P/B ratio is approximately 3.93% higher. Relative to its 5-year average P/B ratio of 5.26, the current P/B ratio is about -15.63% higher. Repligen Corp (RGEN) has a Forward Free Cash Flow (FCF) yield of approximately 1.19%. Compared to its 3-year average FCF yield of 1.28%, the current FCF yield is approximately -7.23% lower. Relative to its 5-year average FCF yield of 0.94%, the current FCF yield is about 26.71% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for RGEN competitors is 210.46, providing a benchmark for relative valuation. Repligen Corp Corp (RGEN.O) exhibits a P/S ratio of 11.59, which is -94.49% above the industry average. Given its robust revenue growth of 18.12%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of RGEN increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of RGEN in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is RGEN currently overvalued or undervalued?

What is Repligen Corp (RGEN) fair value?

RGEN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Repligen Corp (RGEN) is between 92.68 to 138.79 according to relative valuation method.

How does RGEN's valuation metrics compare to the industry average?

The average P/S ratio for RGEN's competitors is 210.46, providing a benchmark for relative valuation. Repligen Corp Corp (RGEN) exhibits a P/S ratio of 11.59, which is -94.49% above the industry average. Given its robust revenue growth of 18.12%, this premium appears unsustainable.

What is the current P/B ratio for Repligen Corp (RGEN) as of Mar 05 2026?

As of Mar 05 2026, Repligen Corp (RGEN) has a P/B ratio of 4.44. This indicates that the market values RGEN at 4.44 times its book value.

What is the current FCF Yield for Repligen Corp (RGEN) as of Mar 05 2026?

As of Mar 05 2026, Repligen Corp (RGEN) has a FCF Yield of 1.19%. This means that for every dollar of Repligen Corp's market capitalization, the company generates 1.19 cents in free cash flow.

What is the current Forward P/E ratio for Repligen Corp (RGEN) as of Mar 05 2026?

As of Mar 05 2026, Repligen Corp (RGEN) has a Forward P/E ratio of 85.23. This means the market is willing to pay $85.23 for every dollar of Repligen Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Repligen Corp (RGEN) as of Mar 05 2026?

As of Mar 05 2026, Repligen Corp (RGEN) has a Forward P/S ratio of 11.59. This means the market is valuing RGEN at $11.59 for every dollar of expected revenue over the next 12 months.

RGEN Valuation